Price $63.73 |
Market Cap
2.59B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
159.8
|
P/B
6.85
|
P/S
5.77
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
39.9
|
Op. Cash Flow
90.2K
|
FCF
1.6
|
|
Op. Margin
10.50%
|
Net Margin
4.60%
|
ROE
7.10%
|
ROI
1.50%
|
|
ROA
2.70%
|
EPS Growth
-
|
Current Ratio
2.6
|
Debt/Equity
166.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Navidea Biopharmaceuticals Inc (NAVB) | $0.20 | - | - | 40.1M | Strong Buy |
| Quorum Health Corp (QHC) | $4.03 | - | - | 140.9M | Strong Buy |
| Integer Holdings Corp (ITGR) | $85.72 | - | - | 2.7B | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $3.35 | - | - | 61.1M | Strong Buy |
| Correvio Pharma Corp (CORV) | $3.14 | - | - | 122.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
